WebbAEWS0031 did not measure length of time to local control, but rather the number of days from the start of one chemotherapy cycle to the start of the next. While the median time for the standard arm on this trial was 21 days in all groups, the median cycle time for the experimental arm ranged from 15–19 days and was influenced by time point of protocol … WebbAEWS0031 Trial of Chemotherapy Intensification Through Interval Compression in Ewing Sarcoma and Related Tumors A Phase III Intergroup Study THIS PROTOCOL IS FOR …
A Randomized Controlled Trial of Interval-Compressed …
Webb2 mars 2024 · The article by Leavey et al 1 reported results of the AEWS1031 trial, which investigated the effects of the addition of vincristine, topotecan, and cyclophosphamide … WebbThe Children’s Oncology Group study ( AEWS0031) showed that compression of chemotherapy cycles into 2 weeks instead of 3 weeks improved survival. Overall, there was a 73% vs 65% event free survival and 83% VS 77% overall survival at 5y for the compressed cycle regimen (B). shishira thomas
Randomized Controlled Trial of Interval-Compressed …
Webb20 nov. 2012 · Purpose: Chemotherapy with alternating vincristine-doxorubicin-cyclophosphamide and ifosfamide-etoposide cycles and primary tumor treatment with surgery and/or radiation therapy constitute the usual approach to localized Ewing sarcoma in North America. http://www.pedsoncologyeducation.com/EwingsChemotherapy.asp WebbHome - ClinicalTrials.gov shishir art and craft